A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.
A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.
复制标题
DOI:
10.1080/19420862.2022.2079449
复制
发表时间:
2022-01
期刊:
影响因子:
5.3
通讯作者:
Heck, Albert J. R.
中科院分区:
文献类型:
--
作者:
de Graaf, Sebastiaan C.;Hoek, Max;Tamara, Sem;Heck, Albert J. R.
A key step in therapeutic and endogenous humoral antibody characterization is identifying the amino acid sequence. So far, this task has been mainly tackled through sequencing of B-cell receptor (BCR) repertoires at the nucleotide level. Mass spectrometry (MS) has emerged as an alternative tool for obtaining sequence information directly at the – most relevant – protein level. Although several MS methods are now well established, analysis of recombinant and endogenous antibodies comes with a specific set of challenges, requiring approaches beyond the conventional proteomics workflows. Here, we review the challenges in MS-based sequencing of both recombinant as well as endogenous humoral antibodies and outline state-of-the-art methods attempting to overcome these obstacles. We highlight recent examples and discuss remaining challenges. We foresee a great future for these approaches making de novo antibody sequencing and discovery by MS-based techniques feasible, even for complex clinical samples from endogenous sources such as serum and other liquid biopsies.
登录
查看更多内容
影响因子:
7.4
作者:
Brodbelt JS
通讯作者:
Brodbelt JS
影响因子:
14.2
作者:
Busse, W;Corren, J;Gupta, N
通讯作者:
Gupta, N
影响因子:
2.9
作者:
Bertsch, Andreas;Leinenbach, Andreas;Kohlbacher, Oliver
通讯作者:
Kohlbacher, Oliver
影响因子:
9.3
作者:
Bondt A;Hoek M;Tamara S;de Graaf B;Peng W;Schulte D;van Rijswijck DMH;den Boer MA;Greisch JF;Varkila MRJ;Snijder J;Cremer OL;Bonten MJM;Heck AJR
通讯作者:
Heck AJR
影响因子:
1.7
作者:
Datta, Ritendra;Bern, Marshall
通讯作者:
Bern, Marshall